

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | virion attachment to host cell (GO:0019062) | 9.67656373 |
| 2 | adhesion of symbiont to host cell (GO:0044650) | 9.67656373 |
| 3 | citrulline biosynthetic process (GO:0019240) | 8.65582528 |
| 4 | peptide cross-linking (GO:0018149) | 8.27234915 |
| 5 | adhesion of symbiont to host (GO:0044406) | 8.12125897 |
| 6 | hair follicle morphogenesis (GO:0031069) | 8.05473046 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.14614191 |
| 8 | intermediate filament cytoskeleton organization (GO:0045104) | 6.67380653 |
| 9 | cell wall macromolecule catabolic process (GO:0016998) | 6.61520523 |
| 10 | cell wall macromolecule metabolic process (GO:0044036) | 6.61520523 |
| 11 | response to interleukin-15 (GO:0070672) | 6.58223540 |
| 12 | intermediate filament-based process (GO:0045103) | 6.45856133 |
| 13 | negative regulation of cell killing (GO:0031342) | 6.32114079 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.32114079 |
| 15 | epidermis development (GO:0008544) | 6.27574770 |
| 16 | negative thymic T cell selection (GO:0045060) | 6.26951350 |
| 17 | negative T cell selection (GO:0043383) | 6.16051011 |
| 18 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.11994871 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 6.04731715 |
| 20 | keratinocyte differentiation (GO:0030216) | 5.95040102 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.93376345 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.80794479 |
| 23 | positive T cell selection (GO:0043368) | 5.79427254 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.78952748 |
| 25 | citrulline metabolic process (GO:0000052) | 5.70836215 |
| 26 | establishment of skin barrier (GO:0061436) | 5.68818814 |
| 27 | hair cycle process (GO:0022405) | 5.50889847 |
| 28 | molting cycle process (GO:0022404) | 5.50889847 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 5.50117428 |
| 30 | positive thymic T cell selection (GO:0045059) | 5.44727296 |
| 31 | thymic T cell selection (GO:0045061) | 5.41867481 |
| 32 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.34399647 |
| 33 | T cell selection (GO:0045058) | 5.31789325 |
| 34 | positive regulation of granulocyte differentiation (GO:0030854) | 5.26474842 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.24386539 |
| 36 | hemidesmosome assembly (GO:0031581) | 5.21767929 |
| 37 | activated T cell proliferation (GO:0050798) | 5.11013562 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.06274899 |
| 39 | peptidyl-arginine modification (GO:0018195) | 5.04415512 |
| 40 | regulation of water loss via skin (GO:0033561) | 5.04305068 |
| 41 | leukocyte aggregation (GO:0070486) | 5.04232811 |
| 42 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.03939592 |
| 43 | skin morphogenesis (GO:0043589) | 4.95750174 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.78197595 |
| 45 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.78183579 |
| 46 | epidermal cell differentiation (GO:0009913) | 4.66394852 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 4.44602974 |
| 48 | tolerance induction (GO:0002507) | 4.15879196 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.14406391 |
| 50 | keratinocyte development (GO:0003334) | 4.11832896 |
| 51 | tooth mineralization (GO:0034505) | 4.05945158 |
| 52 | T cell migration (GO:0072678) | 4.05256746 |
| 53 | hair cycle (GO:0042633) | 33.3381225 |
| 54 | molting cycle (GO:0042303) | 33.3381225 |
| 55 | regulation of T cell tolerance induction (GO:0002664) | 3.93097878 |
| 56 | positive regulation of tolerance induction (GO:0002645) | 3.86378879 |
| 57 | regulation of granulocyte differentiation (GO:0030852) | 3.83893035 |
| 58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.80298682 |
| 59 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.73448962 |
| 60 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.73448962 |
| 61 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.71764329 |
| 62 | regulation of tolerance induction (GO:0002643) | 3.69658656 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.68860294 |
| 64 | hair follicle development (GO:0001942) | 3.64675701 |
| 65 | mast cell activation (GO:0045576) | 3.59401438 |
| 66 | interferon-gamma production (GO:0032609) | 3.53132063 |
| 67 | T cell homeostasis (GO:0043029) | 3.51409262 |
| 68 | positive regulation of hair follicle development (GO:0051798) | 3.51318868 |
| 69 | positive regulation of hair cycle (GO:0042635) | 3.51318868 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 3.49863455 |
| 71 | alpha-beta T cell differentiation (GO:0046632) | 3.44638011 |
| 72 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.42924841 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 3.41412535 |
| 74 | regulation of B cell differentiation (GO:0045577) | 3.41198234 |
| 75 | T cell receptor signaling pathway (GO:0050852) | 3.39622189 |
| 76 | positive regulation of meiotic cell cycle (GO:0051446) | 3.39382889 |
| 77 | mast cell degranulation (GO:0043303) | 3.38639114 |
| 78 | mast cell activation involved in immune response (GO:0002279) | 3.38639114 |
| 79 | histone H3-K36 demethylation (GO:0070544) | 3.38115860 |
| 80 | multicellular organismal water homeostasis (GO:0050891) | 3.37715266 |
| 81 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.37231614 |
| 82 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.37231614 |
| 83 | modulation by symbiont of host immune response (GO:0052553) | 3.37231614 |
| 84 | positive regulation by symbiont of host defense response (GO:0052509) | 3.37231614 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 3.37231614 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.37231614 |
| 87 | bone trabecula formation (GO:0060346) | 3.35303488 |
| 88 | detection of bacterium (GO:0016045) | 3.35048149 |
| 89 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.32262478 |
| 90 | regulation of hair follicle development (GO:0051797) | 3.32112402 |
| 91 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.29328079 |
| 92 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.28842847 |
| 93 | detection of other organism (GO:0098543) | 3.28827833 |
| 94 | embryonic process involved in female pregnancy (GO:0060136) | 3.26963212 |
| 95 | regulation of keratinocyte differentiation (GO:0045616) | 3.23919965 |
| 96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.20399216 |
| 97 | alpha-beta T cell activation (GO:0046631) | 3.19699954 |
| 98 | cellular extravasation (GO:0045123) | 3.18334356 |
| 99 | lymphocyte homeostasis (GO:0002260) | 3.17533452 |
| 100 | Peyers patch development (GO:0048541) | 3.16841169 |
| 101 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.16841169 |
| 102 | ectoderm development (GO:0007398) | 3.15825658 |
| 103 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.15784987 |
| 104 | regulation of regulatory T cell differentiation (GO:0045589) | 3.11891281 |
| 105 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10719825 |
| 106 | negative regulation of adaptive immune response (GO:0002820) | 3.10569182 |
| 107 | positive regulation of B cell differentiation (GO:0045579) | 3.09716804 |
| 108 | natural killer cell differentiation (GO:0001779) | 3.09697956 |
| 109 | response to muramyl dipeptide (GO:0032495) | 3.09665698 |
| 110 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.07703733 |
| 111 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.06677420 |
| 112 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 3.06539016 |
| 113 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.04913781 |
| 114 | leukocyte degranulation (GO:0043299) | 3.03495912 |
| 115 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02360356 |
| 116 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02360356 |
| 117 | negative regulation of type 2 immune response (GO:0002829) | 3.01069540 |
| 118 | epithelium development (GO:0060429) | 2.99925606 |
| 119 | positive regulation of interleukin-2 production (GO:0032743) | 2.97774587 |
| 120 | regulation of hair cycle (GO:0042634) | 2.95284785 |
| 121 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.94075032 |
| 122 | regulation of interleukin-4 production (GO:0032673) | 2.92802742 |
| 123 | germinal center formation (GO:0002467) | 2.88645864 |
| 124 | negative regulation of phagocytosis (GO:0050765) | 2.87783802 |
| 125 | T cell differentiation (GO:0030217) | 2.84312087 |
| 126 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.84133258 |
| 127 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.83186943 |
| 128 | positive regulation of epidermis development (GO:0045684) | 2.82567544 |
| 129 | megakaryocyte development (GO:0035855) | 2.82271136 |
| 130 | interferon-gamma secretion (GO:0072643) | 2.82118313 |
| 131 | water homeostasis (GO:0030104) | 2.82010790 |
| 132 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.80881156 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.80302826 |
| 134 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.79817616 |
| 135 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.78713332 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.75671915 |
| 137 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.74411671 |
| 138 | regulation of alpha-beta T cell activation (GO:0046634) | 2.72719155 |
| 139 | T-helper cell differentiation (GO:0042093) | 2.72454078 |
| 140 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.72454078 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.71593726 |
| 142 | atrioventricular valve morphogenesis (GO:0003181) | 2.70743819 |
| 143 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.70379143 |
| 144 | fatty acid elongation (GO:0030497) | 2.70253718 |
| 145 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.69317813 |
| 146 | gap junction assembly (GO:0016264) | 2.67330008 |
| 147 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.65767722 |
| 148 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.59496310 |
| 149 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.57433917 |
| 150 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.54261776 |
| 151 | establishment of planar polarity (GO:0001736) | 2.50829000 |
| 152 | establishment of tissue polarity (GO:0007164) | 2.50829000 |
| 153 | regulation of epidermis development (GO:0045682) | 2.47993342 |
| 154 | regulation of epidermal cell differentiation (GO:0045604) | 2.47479777 |
| 155 | negative regulation of cell fate specification (GO:0009996) | 2.45284257 |
| 156 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.43894677 |
| 157 | cranial suture morphogenesis (GO:0060363) | 2.38411872 |
| 158 | wound healing, spreading of epidermal cells (GO:0035313) | 2.33930214 |
| 159 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.31390140 |
| 160 | lateral sprouting from an epithelium (GO:0060601) | 2.30473273 |
| 161 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.29981275 |
| 162 | myotube differentiation (GO:0014902) | 2.26889374 |
| 163 | skin development (GO:0043588) | 2.25286785 |
| 164 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.23048510 |
| 165 | lymph vessel development (GO:0001945) | 2.20751852 |
| 166 | non-canonical Wnt signaling pathway (GO:0035567) | 2.18331737 |
| 167 | regulation of keratinocyte proliferation (GO:0010837) | 2.17415830 |
| 168 | cardiac right ventricle morphogenesis (GO:0003215) | 2.16015533 |
| 169 | regulation of cardioblast differentiation (GO:0051890) | 2.14219088 |
| 170 | outflow tract septum morphogenesis (GO:0003148) | 2.13336946 |
| 171 | negative regulation of epidermis development (GO:0045683) | 2.11533042 |
| 172 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.10392257 |
| 173 | positive regulation of meiosis (GO:0045836) | 2.07104402 |
| 174 | phosphatidylserine metabolic process (GO:0006658) | 2.03835185 |
| 175 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.02160192 |
| 176 | regulation of ruffle assembly (GO:1900027) | 2.00491791 |
| 177 | intermediate filament organization (GO:0045109) | 12.0678871 |
| 178 | keratinization (GO:0031424) | 11.1370717 |
| 179 | desmosome organization (GO:0002934) | 10.6078697 |
| 180 | cell communication involved in cardiac conduction (GO:0086065) | 1.97955003 |
| 181 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 1.96805344 |
| 182 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.96524201 |
| 183 | regulation of transforming growth factor beta2 production (GO:0032909) | 1.96506934 |
| 184 | ephrin receptor signaling pathway (GO:0048013) | 1.95637637 |
| 185 | aging (GO:0007568) | 1.93146526 |
| 186 | craniofacial suture morphogenesis (GO:0097094) | 1.92863219 |
| 187 | epithelial cell-cell adhesion (GO:0090136) | 1.86601268 |
| 188 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 1.83802360 |
| 189 | eyelid development in camera-type eye (GO:0061029) | 1.82554313 |
| 190 | cardiac conduction (GO:0061337) | 1.79044596 |
| 191 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 1.78834961 |
| 192 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 1.77364492 |
| 193 | cell-substrate junction assembly (GO:0007044) | 1.76239050 |
| 194 | negative regulation of Ras GTPase activity (GO:0034261) | 1.74400322 |
| 195 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 1.73390188 |
| 196 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 1.71769926 |
| 197 | cardiac muscle cell action potential (GO:0086001) | 1.71086765 |
| 198 | oocyte development (GO:0048599) | 1.70671946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 6.55245646 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.98554398 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.37192812 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73139952 |
| 5 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 4.67119120 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.23615505 |
| 7 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 3.40805480 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.40655529 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.32578049 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.22677843 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.16082359 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.11447069 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.96597099 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.93220376 |
| 15 | MYB_26560356_Chip-Seq_TH1_Human | 2.85793058 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.74138416 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73731654 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.63822981 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.62310455 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.57976215 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56945602 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50887775 |
| 23 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.47509736 |
| 24 | MAF_26560356_Chip-Seq_TH2_Human | 2.45902329 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38100664 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35807865 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33760873 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.26383477 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.25328369 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.24064134 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23822029 |
| 32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.23773199 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23648915 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.22685414 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.18383754 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.16890396 |
| 37 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.15815800 |
| 38 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 2.11517215 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.10127146 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08651883 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08606093 |
| 42 | CTCF_20526341_ChIP-Seq_ESCs_Human | 2.07915660 |
| 43 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.07704836 |
| 44 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.06834081 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 12.7498839 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.99720367 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.99543841 |
| 48 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.94267986 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.93641459 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.91391567 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89797147 |
| 52 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.84537355 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82105199 |
| 54 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.77042850 |
| 55 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.72109129 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.70775171 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.68599417 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64992694 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.63685942 |
| 60 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.61466212 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.59755442 |
| 62 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.59550812 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.58980466 |
| 64 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.56770740 |
| 65 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56552458 |
| 66 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.56063076 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.55999853 |
| 68 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.53431626 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.53249432 |
| 70 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53242361 |
| 71 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52810555 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51948968 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49801937 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.49434863 |
| 75 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48988587 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.44806139 |
| 77 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.44215276 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43780699 |
| 79 | * MNX1_26342078_ChIP-Seq_MIN6-4N_Mouse | 1.42403728 |
| 80 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42321849 |
| 81 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.41832131 |
| 82 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.40349053 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40166055 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.39768570 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.39768570 |
| 86 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39684924 |
| 87 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.38985271 |
| 88 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37079361 |
| 89 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34581288 |
| 90 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.34296339 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33965041 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33677387 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.33640431 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30965635 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30370262 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29135580 |
| 97 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.26805056 |
| 98 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25852608 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25537071 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25451002 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.23066757 |
| 102 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22607817 |
| 103 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.22584346 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 1.20199335 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20141087 |
| 106 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19736192 |
| 107 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19513979 |
| 108 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.18026386 |
| 109 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17503307 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16426090 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13777703 |
| 112 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.13191528 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12962699 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12898249 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12173259 |
| 116 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.11749263 |
| 117 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11461191 |
| 118 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.11243477 |
| 119 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.11171841 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10575111 |
| 121 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10291702 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09290170 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09182059 |
| 124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08825220 |
| 125 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07262931 |
| 126 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07262931 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06687907 |
| 128 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.05682175 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.05488008 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 1.05332811 |
| 131 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05111146 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03594020 |
| 133 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02868503 |
| 134 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02072258 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01441028 |
| 136 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00604553 |
| 137 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.00204578 |
| 138 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00172401 |
| 139 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99711960 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99636478 |
| 141 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.99566843 |
| 142 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99439324 |
| 143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98999265 |
| 144 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.98970054 |
| 145 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98785002 |
| 146 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98162684 |
| 147 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97553264 |
| 148 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97547775 |
| 149 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97290791 |
| 150 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97222388 |
| 151 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96943436 |
| 152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96879383 |
| 153 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96659659 |
| 154 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96401945 |
| 155 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96129306 |
| 156 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95058343 |
| 157 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94877259 |
| 158 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94818900 |
| 159 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94374092 |
| 160 | RXR_22108803_ChIP-Seq_LS180_Human | 0.94280490 |
| 161 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93759007 |
| 162 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.93369470 |
| 163 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91792807 |
| 164 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.91387369 |
| 165 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91247390 |
| 166 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.90121728 |
| 167 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89494338 |
| 168 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89347905 |
| 169 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89251981 |
| 170 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88979365 |
| 171 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88809493 |
| 172 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.88358098 |
| 173 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88313022 |
| 174 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88174847 |
| 175 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87740204 |
| 176 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.87679477 |
| 177 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86669867 |
| 178 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86223988 |
| 179 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85478056 |
| 180 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85423313 |
| 181 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85382175 |
| 182 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.84820521 |
| 183 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84327111 |
| 184 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83707290 |
| 185 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82378313 |
| 186 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81606786 |
| 187 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80382375 |
| 188 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80311254 |
| 189 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78916219 |
| 190 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.78662294 |
| 191 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77661215 |
| 192 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76110990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000579_abnormal_nail_morphology | 8.07995885 |
| 2 | MP0002098_abnormal_vibrissa_morphology | 6.78743570 |
| 3 | MP0000647_abnormal_sebaceous_gland | 6.17611986 |
| 4 | MP0002796_impaired_skin_barrier | 5.68504574 |
| 5 | MP0005275_abnormal_skin_tensile | 5.08153514 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 4.95466819 |
| 7 | MP0000383_abnormal_hair_follicle | 4.87900578 |
| 8 | MP0010678_abnormal_skin_adnexa | 4.29435010 |
| 9 | MP0000377_abnormal_hair_follicle | 3.97205060 |
| 10 | MP0002396_abnormal_hematopoietic_system | 3.93339387 |
| 11 | MP0000427_abnormal_hair_cycle | 3.66430815 |
| 12 | MP0005501_abnormal_skin_physiology | 3.52373345 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 3.47501497 |
| 14 | MP0003436_decreased_susceptibility_to | 3.46113246 |
| 15 | MP0003300_gastrointestinal_ulcer | 3.36923999 |
| 16 | MP0003724_increased_susceptibility_to | 3.29305179 |
| 17 | MP0001800_abnormal_humoral_immune | 3.05463699 |
| 18 | MP0002254_reproductive_system_inflammat | 2.96421537 |
| 19 | MP0000685_abnormal_immune_system | 2.90018735 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.88292115 |
| 21 | MP0005671_abnormal_response_to | 2.70693629 |
| 22 | MP0001216_abnormal_epidermal_layer | 2.66084662 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.63685447 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.54933999 |
| 25 | MP0005387_immune_system_phenotype | 2.52440675 |
| 26 | MP0001790_abnormal_immune_system | 2.52440675 |
| 27 | MP0001819_abnormal_immune_cell | 2.52276807 |
| 28 | MP0004381_abnormal_hair_follicle | 2.50404378 |
| 29 | MP0000703_abnormal_thymus_morphology | 2.46547455 |
| 30 | MP0002723_abnormal_immune_serum | 2.46239277 |
| 31 | MP0009278_abnormal_bone_marrow | 2.34665150 |
| 32 | MP0002398_abnormal_bone_marrow | 2.33798342 |
| 33 | MP0002452_abnormal_antigen_presenting | 2.29826882 |
| 34 | MP0010771_integument_phenotype | 2.27653485 |
| 35 | MP0000367_abnormal_coat/_hair | 2.26874801 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 2.25196686 |
| 37 | MP0005025_abnormal_response_to | 2.23878757 |
| 38 | MP0001243_abnormal_dermal_layer | 2.21707064 |
| 39 | MP0002419_abnormal_innate_immunity | 2.20590906 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 2.13485745 |
| 41 | MP0002060_abnormal_skin_morphology | 2.12336534 |
| 42 | MP0003303_peritoneal_inflammation | 2.11608474 |
| 43 | MP0004947_skin_inflammation | 2.07554200 |
| 44 | MP0000716_abnormal_immune_system | 2.05684459 |
| 45 | MP0000467_abnormal_esophagus_morphology | 2.04606257 |
| 46 | MP0008260_abnormal_autophagy | 1.99875242 |
| 47 | MP0002234_abnormal_pharynx_morphology | 1.94303911 |
| 48 | MP0002722_abnormal_immune_system | 1.89039450 |
| 49 | MP0003866_abnormal_defecation | 1.87437836 |
| 50 | MP0002405_respiratory_system_inflammati | 1.87112222 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.83697168 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.74508030 |
| 53 | MP0010155_abnormal_intestine_physiology | 1.73903421 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.70498370 |
| 55 | MP0000762_abnormal_tongue_morphology | 1.68114778 |
| 56 | MP0002429_abnormal_blood_cell | 1.61359248 |
| 57 | MP0005409_darkened_coat_color | 1.59375224 |
| 58 | MP0009053_abnormal_anal_canal | 1.58074611 |
| 59 | MP0006082_CNS_inflammation | 1.50113909 |
| 60 | MP0009785_altered_susceptibility_to | 1.47865430 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.47627728 |
| 62 | MP0001873_stomach_inflammation | 1.45099551 |
| 63 | MP0009931_abnormal_skin_appearance | 1.41657643 |
| 64 | MP0003828_pulmonary_edema | 1.37006270 |
| 65 | MP0002822_catalepsy | 1.33057920 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.30859125 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.29150728 |
| 68 | MP0003566_abnormal_cell_adhesion | 1.29094501 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.26955462 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.25729029 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.25729029 |
| 72 | MP0001853_heart_inflammation | 1.20682539 |
| 73 | MP0000858_altered_metastatic_potential | 1.16857240 |
| 74 | MP0005310_abnormal_salivary_gland | 1.15974117 |
| 75 | MP0003941_abnormal_skin_development | 1.08338972 |
| 76 | MP0009764_decreased_sensitivity_to | 1.05641861 |
| 77 | MP0001346_abnormal_lacrimal_gland | 1.05458085 |
| 78 | MP0002006_tumorigenesis | 1.03560295 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 1.03488058 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.99650999 |
| 81 | MP0002132_abnormal_respiratory_system | 0.99107970 |
| 82 | MP0002933_joint_inflammation | 0.96859638 |
| 83 | MP0001191_abnormal_skin_condition | 0.93356924 |
| 84 | MP0001661_extended_life_span | 0.92987302 |
| 85 | MP0003172_abnormal_lysosome_physiology | 0.92823508 |
| 86 | MP0002019_abnormal_tumor_incidence | 0.92458869 |
| 87 | MP0000490_abnormal_crypts_of | 0.91887442 |
| 88 | MP0004264_abnormal_extraembryonic_tissu | 0.91420623 |
| 89 | MP0008469_abnormal_protein_level | 0.91306403 |
| 90 | MP0004885_abnormal_endolymph | 0.90946716 |
| 91 | MP0004130_abnormal_muscle_cell | 0.87651287 |
| 92 | MP0001851_eye_inflammation | 0.87013054 |
| 93 | MP0010030_abnormal_orbit_morphology | 0.82166155 |
| 94 | MP0000566_synostosis | 0.82131612 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.81778699 |
| 96 | MP0008057_abnormal_DNA_replication | 0.81259166 |
| 97 | MP0004883_abnormal_blood_vessel | 0.80896876 |
| 98 | MP0002282_abnormal_trachea_morphology | 0.77637577 |
| 99 | MP0001340_abnormal_eyelid_morphology | 0.77511417 |
| 100 | MP0002277_abnormal_respiratory_mucosa | 0.76494058 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.76315264 |
| 102 | MP0008961_abnormal_basal_metabolism | 0.73121861 |
| 103 | MP0005166_decreased_susceptibility_to | 0.70735352 |
| 104 | MP0003755_abnormal_palate_morphology | 0.70265450 |
| 105 | MP0005535_abnormal_body_temperature | 0.69778654 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.68519818 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.67563893 |
| 108 | MP0004510_myositis | 0.64074279 |
| 109 | MP0001663_abnormal_digestive_system | 0.62025575 |
| 110 | MP0008438_abnormal_cutaneous_collagen | 0.60702055 |
| 111 | MP0003315_abnormal_perineum_morphology | 0.60192975 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.57931094 |
| 113 | MP0009115_abnormal_fat_cell | 0.56995136 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.56857927 |
| 115 | MP0008873_increased_physiological_sensi | 0.56575134 |
| 116 | MP0000627_abnormal_mammary_gland | 0.56477934 |
| 117 | MP0004484_altered_response_of | 0.55573924 |
| 118 | MP0003448_altered_tumor_morphology | 0.55499845 |
| 119 | MP0003045_fibrosis | 0.54038525 |
| 120 | MP0001849_ear_inflammation | 0.53073970 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.53009308 |
| 122 | MP0003221_abnormal_cardiomyocyte_apopto | 0.52816738 |
| 123 | MP0000249_abnormal_blood_vessel | 0.52459897 |
| 124 | MP0003787_abnormal_imprinting | 0.51290610 |
| 125 | MP0002877_abnormal_melanocyte_morpholog | 0.50473474 |
| 126 | MP0003385_abnormal_body_wall | 0.48695302 |
| 127 | MP0009763_increased_sensitivity_to | 0.48115984 |
| 128 | MP0003795_abnormal_bone_structure | 0.45590661 |
| 129 | MP0001188_hyperpigmentation | 0.45020342 |
| 130 | MP0008874_decreased_physiological_sensi | 0.44521885 |
| 131 | MP0002111_abnormal_tail_morphology | 0.44517688 |
| 132 | MP0008004_abnormal_stomach_pH | 0.43425697 |
| 133 | MP0008877_abnormal_DNA_methylation | 0.42972357 |
| 134 | MP0002970_abnormal_white_adipose | 0.40653661 |
| 135 | MP0001784_abnormal_fluid_regulation | 0.40614044 |
| 136 | MP0005451_abnormal_body_composition | 0.36780693 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.36348102 |
| 138 | MP0005023_abnormal_wound_healing | 0.35471033 |
| 139 | MP0002177_abnormal_outer_ear | 0.34245866 |
| 140 | MP0003950_abnormal_plasma_membrane | 0.33973509 |
| 141 | MP0002697_abnormal_eye_size | 0.33111952 |
| 142 | MP0000516_abnormal_urinary_system | 0.28705531 |
| 143 | MP0005367_renal/urinary_system_phenotyp | 0.28705531 |
| 144 | MP0000537_abnormal_urethra_morphology | 0.27976058 |
| 145 | MP0006054_spinal_hemorrhage | 0.27694135 |
| 146 | MP0000678_abnormal_parathyroid_gland | 0.27442634 |
| 147 | MP0005075_abnormal_melanosome_morpholog | 0.25475619 |
| 148 | MP0004272_abnormal_basement_membrane | 0.25212096 |
| 149 | MP0000432_abnormal_head_morphology | 0.24335485 |
| 150 | MP0003935_abnormal_craniofacial_develop | 0.24035358 |
| 151 | MP0002837_dystrophic_cardiac_calcinosis | 0.22846020 |
| 152 | MP0000462_abnormal_digestive_system | 0.22652691 |
| 153 | MP0000751_myopathy | 0.21261202 |
| 154 | MP0002233_abnormal_nose_morphology | 0.19513888 |
| 155 | MP0000465_gastrointestinal_hemorrhage | 0.19010122 |
| 156 | MP0003191_abnormal_cellular_cholesterol | 0.18452324 |
| 157 | MP0005076_abnormal_cell_differentiation | 0.17438891 |
| 158 | MP0004742_abnormal_vestibular_system | 0.15418053 |
| 159 | MP0008569_lethality_at_weaning | 0.14723910 |
| 160 | MP0003329_amyloid_beta_deposits | 0.13988668 |
| 161 | MP0008770_decreased_survivor_rate | 0.12168527 |
| 162 | MP0010352_gastrointestinal_tract_polyps | 0.12150065 |
| 163 | MP0004858_abnormal_nervous_system | 0.12075473 |
| 164 | MP0000013_abnormal_adipose_tissue | 0.11792690 |
| 165 | MP0005193_abnormal_anterior_eye | 0.11181638 |
| 166 | MP0002653_abnormal_ependyma_morphology | 0.10881792 |
| 167 | MP0002735_abnormal_chemical_nociception | 0.10655227 |
| 168 | MP0003937_abnormal_limbs/digits/tail_de | 0.10362584 |
| 169 | MP0002109_abnormal_limb_morphology | 0.10234070 |
| 170 | MP0004859_abnormal_synaptic_plasticity | 0.09842770 |
| 171 | MP0001286_abnormal_eye_development | 0.09734791 |
| 172 | MP0000538_abnormal_urinary_bladder | 0.08903110 |
| 173 | MP0001270_distended_abdomen | 0.08896881 |
| 174 | MP0005508_abnormal_skeleton_morphology | 0.08788034 |
| 175 | MP0003119_abnormal_digestive_system | 0.08763024 |
| 176 | MP0001879_abnormal_lymphatic_vessel | 0.08168634 |
| 177 | MP0002009_preneoplasia | 0.07752027 |
| 178 | MP0002116_abnormal_craniofacial_bone | 0.07413175 |
| 179 | MP0003763_abnormal_thymus_physiology | 0.06965114 |
| 180 | MP0004036_abnormal_muscle_relaxation | 0.05919563 |
| 181 | MP0000049_abnormal_middle_ear | 0.05853321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pili torti (HP:0003777) | 9.85109243 |
| 2 | Brittle hair (HP:0002299) | 9.46828552 |
| 3 | Nail dystrophy (HP:0008404) | 6.95946819 |
| 4 | Abnormality of nail color (HP:0100643) | 6.69756698 |
| 5 | Eczematoid dermatitis (HP:0000976) | 6.17902823 |
| 6 | Abnormal hair laboratory examination (HP:0003328) | 6.17816611 |
| 7 | Fragile nails (HP:0001808) | 5.89429068 |
| 8 | Stomatitis (HP:0010280) | 5.76153072 |
| 9 | Follicular hyperkeratosis (HP:0007502) | 5.38557667 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.26850525 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.22394009 |
| 12 | Alopecia of scalp (HP:0002293) | 5.11649590 |
| 13 | Pustule (HP:0200039) | 4.94059817 |
| 14 | Fine hair (HP:0002213) | 4.92210640 |
| 15 | Palmoplantar hyperkeratosis (HP:0000972) | 4.92020749 |
| 16 | Myositis (HP:0100614) | 4.92011415 |
| 17 | Onycholysis (HP:0001806) | 4.78936517 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 4.72924689 |
| 19 | T lymphocytopenia (HP:0005403) | 4.72457345 |
| 20 | Thick nail (HP:0001805) | 4.66228532 |
| 21 | Palmar hyperkeratosis (HP:0010765) | 4.61838857 |
| 22 | Plantar hyperkeratosis (HP:0007556) | 4.54405301 |
| 23 | Abnormality of T cell number (HP:0011839) | 4.35530388 |
| 24 | Right ventricular cardiomyopathy (HP:0011663) | 4.26437194 |
| 25 | Increased IgE level (HP:0003212) | 4.19641967 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 4.15681298 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.99677803 |
| 28 | Recurrent fungal infections (HP:0002841) | 3.91991744 |
| 29 | Milia (HP:0001056) | 3.90872504 |
| 30 | Prolonged bleeding time (HP:0003010) | 3.80786896 |
| 31 | Sparse eyelashes (HP:0000653) | 3.75938669 |
| 32 | Granulocytopenia (HP:0001913) | 3.68930335 |
| 33 | Abnormality of T cells (HP:0002843) | 3.67475730 |
| 34 | Oral leukoplakia (HP:0002745) | 3.64868051 |
| 35 | Erythema (HP:0010783) | 3.56185542 |
| 36 | Meningitis (HP:0001287) | 3.46801814 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.31553385 |
| 38 | Recurrent viral infections (HP:0004429) | 3.27904229 |
| 39 | Recurrent skin infections (HP:0001581) | 3.27444207 |
| 40 | Stomach cancer (HP:0012126) | 3.26313168 |
| 41 | Orchitis (HP:0100796) | 3.23147227 |
| 42 | Amelogenesis imperfecta (HP:0000705) | 3.22527950 |
| 43 | Abnormality of the frontal sinuses (HP:0002687) | 3.21726264 |
| 44 | Verrucae (HP:0200043) | 3.21133265 |
| 45 | Papilloma (HP:0012740) | 3.21133265 |
| 46 | Papilledema (HP:0001085) | 3.19940817 |
| 47 | Spontaneous hematomas (HP:0007420) | 3.19001281 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 3.17895729 |
| 49 | Optic neuritis (HP:0100653) | 3.17895729 |
| 50 | Encephalitis (HP:0002383) | 3.12347220 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.10932728 |
| 52 | Recurrent cutaneous fungal infections (HP:0011370) | 3.10932728 |
| 53 | Eosinophilia (HP:0001880) | 3.08218207 |
| 54 | Leukocytosis (HP:0001974) | 3.05597201 |
| 55 | Abnormality of macrophages (HP:0004311) | 3.01205805 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 3.01073821 |
| 57 | IgG deficiency (HP:0004315) | 3.00451057 |
| 58 | Parakeratosis (HP:0001036) | 2.97550449 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.97024947 |
| 60 | Congenital, generalized hypertrichosis (HP:0004540) | 2.92749230 |
| 61 | IgM deficiency (HP:0002850) | 2.89328421 |
| 62 | Gastrointestinal infarctions (HP:0005244) | 2.87087642 |
| 63 | Increased IgM level (HP:0003496) | 2.86912408 |
| 64 | Hypergammaglobulinemia (HP:0010702) | 2.85244126 |
| 65 | Basal cell carcinoma (HP:0002671) | 2.84184809 |
| 66 | Curly hair (HP:0002212) | 2.81313405 |
| 67 | Inflammation of the large intestine (HP:0002037) | 2.79663726 |
| 68 | Vasculitis (HP:0002633) | 2.78346390 |
| 69 | Lymphopenia (HP:0001888) | 2.77991847 |
| 70 | Ridged nail (HP:0001807) | 2.77470712 |
| 71 | Erythroderma (HP:0001019) | 2.77248520 |
| 72 | Abnormality of eosinophils (HP:0001879) | 2.75940541 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.75922861 |
| 74 | Aplasia cutis congenita (HP:0001057) | 2.75462611 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67772940 |
| 76 | Hypochromic anemia (HP:0001931) | 2.64702256 |
| 77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.58210152 |
| 78 | Obstructive lung disease (HP:0006536) | 2.55646916 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55646916 |
| 80 | Hypochromic microcytic anemia (HP:0004840) | 2.53883834 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.53203918 |
| 82 | Intention tremor (HP:0002080) | 2.51962512 |
| 83 | Abnormal blistering of the skin (HP:0008066) | 2.51474475 |
| 84 | Urticaria (HP:0001025) | 2.48860169 |
| 85 | Cellulitis (HP:0100658) | 2.47041032 |
| 86 | Chest pain (HP:0100749) | 2.46476826 |
| 87 | Agammaglobulinemia (HP:0004432) | 2.44186628 |
| 88 | Abnormality of the fingertips (HP:0001211) | 2.43339997 |
| 89 | Neck muscle weakness (HP:0000467) | 2.43171315 |
| 90 | Combined immunodeficiency (HP:0005387) | 2.42656984 |
| 91 | Natal tooth (HP:0000695) | 2.42163644 |
| 92 | Dry hair (HP:0011359) | 2.39837823 |
| 93 | Epistaxis (HP:0000421) | 2.39183294 |
| 94 | Viral hepatitis (HP:0006562) | 2.39174013 |
| 95 | Torticollis (HP:0000473) | 2.39024892 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 2.36079442 |
| 97 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.32881003 |
| 98 | Advanced eruption of teeth (HP:0006288) | 2.29959994 |
| 99 | Abnormality of the parietal bone (HP:0002696) | 2.27674004 |
| 100 | Seborrheic dermatitis (HP:0001051) | 2.27548473 |
| 101 | Gingivitis (HP:0000230) | 2.25724044 |
| 102 | Absent eyelashes (HP:0000561) | 2.20113062 |
| 103 | Facial diplegia (HP:0001349) | 2.19178163 |
| 104 | Colitis (HP:0002583) | 2.16215016 |
| 105 | Episodic fever (HP:0001954) | 2.12945468 |
| 106 | Syringomyelia (HP:0003396) | 2.10994602 |
| 107 | Spinal cord lesions (HP:0100561) | 2.10994602 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10084954 |
| 109 | Pulmonary infiltrates (HP:0002113) | 2.09231417 |
| 110 | Abnormality of the periventricular white matter (HP:0002518) | 2.08054411 |
| 111 | Recurrent bronchitis (HP:0002837) | 2.07412565 |
| 112 | Corneal erosion (HP:0200020) | 2.05548325 |
| 113 | Hypohidrosis (HP:0000966) | 2.05190280 |
| 114 | Slow saccadic eye movements (HP:0000514) | 2.04342750 |
| 115 | Craniofacial dystonia (HP:0012179) | 2.04302962 |
| 116 | Pulmonary embolism (HP:0002204) | 2.03689952 |
| 117 | Coarse hair (HP:0002208) | 2.01864132 |
| 118 | Skin ulcer (HP:0200042) | 2.01417511 |
| 119 | Hypotrichosis (HP:0001006) | 13.7997898 |
| 120 | Woolly hair (HP:0002224) | 11.1890630 |
| 121 | Abnormality of hair growth rate (HP:0011363) | 10.2557186 |
| 122 | Slow-growing hair (HP:0002217) | 10.2557186 |
| 123 | Palmoplantar keratoderma (HP:0000982) | 1.99494056 |
| 124 | Joint swelling (HP:0001386) | 1.97680785 |
| 125 | Supernumerary ribs (HP:0005815) | 1.96262567 |
| 126 | Abnormality of the columella (HP:0009929) | 1.96137406 |
| 127 | Lymphoma (HP:0002665) | 1.95431382 |
| 128 | Ventricular tachycardia (HP:0004756) | 1.93192537 |
| 129 | Concave nail (HP:0001598) | 1.92763055 |
| 130 | Gingival bleeding (HP:0000225) | 1.91874282 |
| 131 | Sepsis (HP:0100806) | 1.91210051 |
| 132 | Focal dystonia (HP:0004373) | 1.90162783 |
| 133 | Hemoptysis (HP:0002105) | 1.90122257 |
| 134 | Gangrene (HP:0100758) | 1.89968392 |
| 135 | Microcytic anemia (HP:0001935) | 1.89828265 |
| 136 | Abnormality of permanent molar morphology (HP:0011071) | 1.89791406 |
| 137 | Abnormality of the dental root (HP:0006486) | 1.89791406 |
| 138 | Taurodontia (HP:0000679) | 1.89791406 |
| 139 | Alveolar cell carcinoma (HP:0006519) | 1.85375951 |
| 140 | Abnormality of molar morphology (HP:0011070) | 1.85361911 |
| 141 | Abnormality of molar (HP:0011077) | 1.85361911 |
| 142 | Ventricular fibrillation (HP:0001663) | 1.85213533 |
| 143 | Lip pit (HP:0100267) | 1.83992447 |
| 144 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.83248756 |
| 145 | Pruritus (HP:0000989) | 1.82074536 |
| 146 | Abnormality of dental color (HP:0011073) | 1.81641252 |
| 147 | Recurrent corneal erosions (HP:0000495) | 1.80378736 |
| 148 | Abnormality of the pupil (HP:0000615) | 1.80332897 |
| 149 | Difficulty walking (HP:0002355) | 1.73689760 |
| 150 | Conjunctival hamartoma (HP:0100780) | 1.72850599 |
| 151 | Blepharitis (HP:0000498) | 1.72728981 |
| 152 | Fatigable weakness (HP:0003473) | 1.67302689 |
| 153 | Abnormality of the neuromuscular junction (HP:0003398) | 1.67302689 |
| 154 | Atrophic scars (HP:0001075) | 1.65054457 |
| 155 | Widely patent fontanelles and sutures (HP:0004492) | 1.64927247 |
| 156 | Abnormality of the dental pulp (HP:0006479) | 1.64403078 |
| 157 | Amniotic constriction ring (HP:0009775) | 1.61309239 |
| 158 | Abnormality of placental membranes (HP:0011409) | 1.61309239 |
| 159 | Autoamputation (HP:0001218) | 1.56741306 |
| 160 | Carious teeth (HP:0000670) | 1.53404024 |
| 161 | Anonychia (HP:0001798) | 1.46675619 |
| 162 | Acanthosis nigricans (HP:0000956) | 1.45713529 |
| 163 | Abnormality of the aortic arch (HP:0012303) | 1.44442115 |
| 164 | Hyporeflexia of lower limbs (HP:0002600) | 1.44116467 |
| 165 | Heterogeneous (HP:0001425) | 1.42452347 |
| 166 | Sparse scalp hair (HP:0002209) | 1.40782644 |
| 167 | Widely spaced teeth (HP:0000687) | 1.39346945 |
| 168 | Sudden death (HP:0001699) | 1.38886882 |
| 169 | Type 1 muscle fiber predominance (HP:0003803) | 1.38652710 |
| 170 | Abnormality of the fingernails (HP:0001231) | 1.38070295 |
| 171 | Unilateral renal agenesis (HP:0000122) | 1.37698398 |
| 172 | Laryngomalacia (HP:0001601) | 1.34320172 |
| 173 | Keratoconjunctivitis sicca (HP:0001097) | 1.32838281 |
| 174 | Fragile skin (HP:0001030) | 1.32170670 |
| 175 | Achilles tendon contracture (HP:0001771) | 1.31581317 |
| 176 | Craniofacial hyperostosis (HP:0004493) | 1.31225175 |
| 177 | Round ear (HP:0100830) | 1.29830396 |
| 178 | Increased connective tissue (HP:0009025) | 1.25164669 |
| 179 | Ectropion (HP:0000656) | 1.24290384 |
| 180 | Hypoplastic labia majora (HP:0000059) | 1.22985298 |
| 181 | Abnormality of the Achilles tendon (HP:0005109) | 1.21168015 |
| 182 | Down-sloping shoulders (HP:0200021) | 1.20799850 |
| 183 | Corneal dystrophy (HP:0001131) | 1.20733018 |
| 184 | Neonatal onset (HP:0003623) | 1.20368297 |
| 185 | Selective tooth agenesis (HP:0001592) | 1.19785748 |
| 186 | Distal lower limb muscle weakness (HP:0009053) | 1.18237918 |
| 187 | Keratoconjunctivitis (HP:0001096) | 1.18179447 |
| 188 | Hyperhidrosis (HP:0000975) | 1.15470444 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.99377256 |
| 2 | MAP3K6 | 4.45124002 |
| 3 | FER | 4.04263445 |
| 4 | EPHA2 | 3.76146189 |
| 5 | RIPK4 | 3.64531091 |
| 6 | MAPKAPK3 | 3.59712911 |
| 7 | TXK | 3.58519311 |
| 8 | EPHB2 | 3.43775414 |
| 9 | PRPF4B | 3.41825499 |
| 10 | TAOK1 | 3.31535524 |
| 11 | NME1 | 3.04258698 |
| 12 | ERN1 | 2.83376162 |
| 13 | LATS1 | 2.80323968 |
| 14 | JAK3 | 2.68101891 |
| 15 | MAP3K11 | 2.44670039 |
| 16 | MAP3K3 | 2.41252966 |
| 17 | ZAP70 | 2.35847314 |
| 18 | TAOK3 | 2.26391670 |
| 19 | GRK6 | 2.24084387 |
| 20 | NLK | 2.19310149 |
| 21 | ITK | 2.15988024 |
| 22 | LATS2 | 2.15769936 |
| 23 | MAP3K12 | 2.04879172 |
| 24 | MAP3K2 | 1.97506959 |
| 25 | TRIB3 | 1.92756999 |
| 26 | FES | 1.88353968 |
| 27 | SIK3 | 1.87898101 |
| 28 | CSK | 1.82418807 |
| 29 | MAP3K9 | 1.81247498 |
| 30 | MAP2K4 | 1.77193564 |
| 31 | BTK | 1.77106508 |
| 32 | TYK2 | 1.76852413 |
| 33 | BCR | 1.73315322 |
| 34 | MAP3K14 | 1.65407694 |
| 35 | SYK | 1.65021073 |
| 36 | DYRK3 | 1.64810760 |
| 37 | EEF2K | 1.64685149 |
| 38 | FGFR2 | 1.60643463 |
| 39 | MAP3K13 | 1.56189738 |
| 40 | PIK3CG | 1.53953013 |
| 41 | IRAK4 | 1.51705322 |
| 42 | ERBB4 | 1.49424421 |
| 43 | TNK2 | 1.47057867 |
| 44 | MAP3K1 | 1.46759574 |
| 45 | HCK | 1.43721771 |
| 46 | LCK | 1.40378413 |
| 47 | RPS6KB2 | 1.38591772 |
| 48 | TTN | 1.36325802 |
| 49 | CDK12 | 1.33620660 |
| 50 | SIK1 | 1.32186441 |
| 51 | IKBKE | 1.30734838 |
| 52 | MARK3 | 1.27922455 |
| 53 | ZAK | 1.27016624 |
| 54 | SIK2 | 1.23563614 |
| 55 | CAMKK2 | 1.23467215 |
| 56 | STK38L | 1.20679506 |
| 57 | MAP2K6 | 1.17130541 |
| 58 | KSR2 | 1.16745026 |
| 59 | FGFR1 | 1.14242162 |
| 60 | MAPK7 | 1.10582703 |
| 61 | PASK | 1.09921406 |
| 62 | MAP3K7 | 1.08519399 |
| 63 | TEC | 1.05815836 |
| 64 | HIPK2 | 1.05011937 |
| 65 | RIPK1 | 1.04138858 |
| 66 | MST1R | 1.02983974 |
| 67 | AKT3 | 1.02005294 |
| 68 | LYN | 0.99845038 |
| 69 | CAMKK1 | 0.98466268 |
| 70 | EPHB1 | 0.97895689 |
| 71 | STK38 | 0.97376953 |
| 72 | NTRK2 | 0.97305636 |
| 73 | PIM1 | 0.95587719 |
| 74 | DDR2 | 0.95323892 |
| 75 | BMX | 0.94866670 |
| 76 | FGFR3 | 0.94533307 |
| 77 | CDK6 | 0.94105098 |
| 78 | STK10 | 0.88847051 |
| 79 | BRD4 | 0.85883040 |
| 80 | SMG1 | 0.82826037 |
| 81 | MAPKAPK2 | 0.81537126 |
| 82 | FGFR4 | 0.80250141 |
| 83 | NEK1 | 0.79805560 |
| 84 | JAK2 | 0.78971933 |
| 85 | NTRK3 | 0.78084336 |
| 86 | TBK1 | 0.77820483 |
| 87 | PDGFRA | 0.76450547 |
| 88 | DYRK1B | 0.73872521 |
| 89 | BMPR2 | 0.73774322 |
| 90 | CDK4 | 0.73428746 |
| 91 | MAP3K5 | 0.70606827 |
| 92 | PRKCQ | 0.69523754 |
| 93 | IKBKB | 0.69235993 |
| 94 | MAP2K1 | 0.68944207 |
| 95 | KIT | 0.67923839 |
| 96 | IRAK1 | 0.66431521 |
| 97 | SGK2 | 0.64861921 |
| 98 | PAK6 | 0.63430465 |
| 99 | LIMK1 | 0.61450234 |
| 100 | TRPM7 | 0.59844543 |
| 101 | FGR | 0.59210892 |
| 102 | PRKD1 | 0.58351538 |
| 103 | PRKCI | 0.58144643 |
| 104 | MAP3K10 | 0.57819546 |
| 105 | PTK6 | 0.56758704 |
| 106 | OBSCN | 0.56709542 |
| 107 | MAPK11 | 0.55718072 |
| 108 | PRKCH | 0.55251403 |
| 109 | PDK1 | 0.54778176 |
| 110 | CDK19 | 0.54466237 |
| 111 | MELK | 0.54425963 |
| 112 | PTK2 | 0.50836362 |
| 113 | PDGFRB | 0.48547234 |
| 114 | PAK4 | 0.48212140 |
| 115 | MINK1 | 0.47688708 |
| 116 | TESK1 | 0.47272561 |
| 117 | MST4 | 0.47014659 |
| 118 | RPS6KA4 | 0.46991915 |
| 119 | YES1 | 0.46119115 |
| 120 | TYRO3 | 0.45710299 |
| 121 | RET | 0.44638299 |
| 122 | DMPK | 0.43922429 |
| 123 | CSF1R | 0.43886088 |
| 124 | RPS6KA1 | 0.41979485 |
| 125 | CSNK1E | 0.41009475 |
| 126 | FYN | 0.40403070 |
| 127 | PRKACA | 0.40341317 |
| 128 | PAK3 | 0.39856120 |
| 129 | ERBB2 | 0.39656810 |
| 130 | NTRK1 | 0.39081734 |
| 131 | ERBB3 | 0.38646607 |
| 132 | SGK494 | 0.38422059 |
| 133 | SGK223 | 0.38422059 |
| 134 | KSR1 | 0.37707613 |
| 135 | MET | 0.36803927 |
| 136 | PKN2 | 0.36240351 |
| 137 | CAMK4 | 0.35615296 |
| 138 | CDC42BPA | 0.35209756 |
| 139 | STK11 | 0.35054303 |
| 140 | EPHA3 | 0.34353059 |
| 141 | SGK1 | 0.33584714 |
| 142 | MARK2 | 0.33516797 |
| 143 | MAPK3 | 0.32965102 |
| 144 | MAP2K3 | 0.32597804 |
| 145 | SGK3 | 0.32463765 |
| 146 | BLK | 0.32168738 |
| 147 | GSK3A | 0.31708527 |
| 148 | KDR | 0.31093349 |
| 149 | EPHA4 | 0.30635305 |
| 150 | ALK | 0.29728426 |
| 151 | CSNK1A1 | 0.28843262 |
| 152 | MAP2K2 | 0.28764904 |
| 153 | CSNK1A1L | 0.28445793 |
| 154 | ICK | 0.28068943 |
| 155 | MAPK8 | 0.27629687 |
| 156 | PRKACG | 0.27605755 |
| 157 | CSNK1D | 0.26651560 |
| 158 | PIM2 | 0.26410084 |
| 159 | CDK5 | 0.26095409 |
| 160 | MAPK12 | 0.25308235 |
| 161 | PKN1 | 0.23679553 |
| 162 | JAK1 | 0.23371930 |
| 163 | PHKG1 | 0.22307727 |
| 164 | PHKG2 | 0.22307727 |
| 165 | MAPK9 | 0.21685163 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 4.23947105 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 4.18409353 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.39826616 |
| 4 | Basal cell carcinoma_Homo sapiens_hsa05217 | 3.07559961 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.82691529 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.81724928 |
| 7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.65677669 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.41485275 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37656364 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.32618807 |
| 11 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.31062943 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.30691890 |
| 13 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.08834758 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.03187007 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99446652 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95423059 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.95090330 |
| 18 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.94705813 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92877048 |
| 20 | Melanogenesis_Homo sapiens_hsa04916 | 1.80624716 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.75514220 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.72592095 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.70271835 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.67083406 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.66765643 |
| 26 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64915986 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58048932 |
| 28 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.57900573 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54490500 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53713624 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49419924 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.47968427 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47000323 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46961203 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44451980 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.43496767 |
| 37 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.42274491 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.41944047 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.40083910 |
| 40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.39340935 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.39335760 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.38621316 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.37650644 |
| 44 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37188128 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.37152178 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.36808801 |
| 47 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.35343758 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 1.32118427 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31917320 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28751425 |
| 51 | Tight junction_Homo sapiens_hsa04530 | 1.28155431 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.27277310 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25093561 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 1.24505359 |
| 55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.24046765 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.23922963 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23479259 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23154535 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.22533416 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.21218187 |
| 61 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.19361095 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16123537 |
| 63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14070557 |
| 64 | Platelet activation_Homo sapiens_hsa04611 | 1.13524316 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.13072810 |
| 66 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.11091855 |
| 67 | Malaria_Homo sapiens_hsa05144 | 1.10961491 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10648940 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10367812 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09769786 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.09645225 |
| 72 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.08683588 |
| 73 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.08489110 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08308034 |
| 75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.06831662 |
| 76 | Endometrial cancer_Homo sapiens_hsa05213 | 1.06472847 |
| 77 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.04435801 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.04271547 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02564487 |
| 80 | HTLV-I infection_Homo sapiens_hsa05166 | 1.00416756 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 1.00242347 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.99384333 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98236512 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97519193 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.97193136 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.94762937 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93256293 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93226512 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.88121748 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87493942 |
| 91 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.87213561 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84487846 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83070947 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81742814 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80135996 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80056699 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78872038 |
| 98 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78681117 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.78539196 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76284409 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.76086929 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74663085 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74144716 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.72464096 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72376780 |
| 106 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.72350733 |
| 107 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69289147 |
| 108 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.68978855 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68881777 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.66785458 |
| 111 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66285395 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65004792 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64629451 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.64400582 |
| 115 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64181000 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.63725652 |
| 117 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62733793 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62192827 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62054487 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.61721775 |
| 121 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61135716 |
| 122 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60200132 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59650093 |
| 124 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59327649 |
| 125 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59253365 |
| 126 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58885588 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58218514 |
| 128 | Pertussis_Homo sapiens_hsa05133 | 0.56953205 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55550846 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.55277117 |
| 131 | Melanoma_Homo sapiens_hsa05218 | 0.55032321 |
| 132 | Circadian entrainment_Homo sapiens_hsa04713 | 0.54519647 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54328631 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.53879296 |
| 135 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53622127 |
| 136 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52098549 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.51520479 |
| 138 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50903311 |
| 139 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50834126 |
| 140 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50423364 |
| 141 | Renin secretion_Homo sapiens_hsa04924 | 0.50295247 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50114814 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48985352 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.48870071 |
| 145 | Phototransduction_Homo sapiens_hsa04744 | 0.48703998 |
| 146 | Salivary secretion_Homo sapiens_hsa04970 | 0.48461874 |
| 147 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47738427 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47679897 |
| 149 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47542925 |
| 150 | Legionellosis_Homo sapiens_hsa05134 | 0.47510155 |
| 151 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47171063 |
| 152 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46900846 |
| 153 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46629455 |
| 154 | Phagosome_Homo sapiens_hsa04145 | 0.45808320 |
| 155 | Olfactory transduction_Homo sapiens_hsa04740 | 0.45224098 |
| 156 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44673739 |
| 157 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43056876 |
| 158 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42603120 |
| 159 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41844913 |
| 160 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40707963 |
| 161 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40384226 |
| 162 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39678274 |
| 163 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39187915 |
| 164 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38191919 |
| 165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37603649 |
| 166 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37413835 |
| 167 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37078978 |
| 168 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37006815 |
| 169 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36761083 |
| 170 | Prostate cancer_Homo sapiens_hsa05215 | 0.36461793 |

